A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA

BACKGROUND The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak. METHODS In this phase 1 study, we administered a single dose of the chimpanzee adenovirus 3 (ChAd3) vaccine encoding the surface glycoprotein of Zaire ebolavirus (ZEBOV) to 60 healthy adult volunteers in Oxford, United Kingdom. The vaccine was administered in three dose levels — 1×1010 viral particles, 2.5×1010 viral particles, and 5×1010 viral particles — with 20 participants in each group. We then assessed the effect of adding a booster dose of a modified vaccinia Ankara (MVA) strain, encoding the same Ebola virus glyco- protein, in 30 of the 60 participants and evaluated a reduced prime–boost interval in another 16 participants. We also compared antibody responses to inactivated whole Ebola virus virions and neutralizing antibody activity with those observed in phase 1 studies of a recombinant vesicular stomatitis virus–based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) to determine relative potency and assess durability. RESULTS No safety concerns were identified at any of the dose levels studied. Four weeks after immunization with the ChAd3 vaccine, ZEBOV-specific antibody responses were similar to those induced by rVSV-ZEBOV vaccination, with a geometric mean titer of 752 and 921, respectively. ZEBOV neutralization activity was also similar with the two vaccines (geo- metric mean titer, 14.9 and 22.2, respectively). Boosting with the MVA vector increased virus-specific antibodies by a factor of 12 (geometric mean titer, 9007) and increased glycoprotein-specific CD8+ T cells by a factor of 5. Significant increases in neutralizing antibodies were seen after boosting in all 30 participants (geometric mean titer, 139; P<0.001). Virus-specific antibody responses in participants primed with ChAd3 remained positive 6 months after vaccination (geometric mean titer, 758) but were significantly higher in those who had received the MVA booster (geometric mean titer, 1750; P<0.001). CONCLUSIONS The ChAd3 vaccine boosted with MVA elicited B-cell and T-cell immune responses to ZEBOV that were superior to those induced by the ChAd3 vaccine alone. (Funded by the Wellcome Trust and others; ClinicalTrials.gov number, NCT02240875.

Search for neutrinoless decays tau -> lhh and tau -> lV0

We have searched for neutrinoless tau lepton decays into l h h or l V0, where l stands for an electron or muon, h for a charged light hadron, pi or K, and V0 for a neutral vector meson, rho, K*(892) and phi, using a 158 /fb data sample collected with the Belle detector at the KEKB e+e- collider. Since the number of events observed are consistent with the expected background, we set upper limits on the branching fractions in the range of 1.6-8.0 x 10-7 for various decay modes at the 90% confidence level.Comment: 15 pages, 4 figures, 2 tables, submitted to Phys. Lett.

Dinâmica populacional de células mielóides durante o curso de inflamação crônica em camundongos C57BL/6 infectados com Toxoplasma gondii Population dynamics of myeloid cells during the course of chronic inflammation in C57 BL/6 mice infected with Toxoplasma gondii

Fagócitos mononucleares (Mø) e polimorfo-nucleares neutrófilos (PMN) foram analisados durante o curso da infecção por Toxoplasma gondii em camundongos C57 BL/6, fêmeas, portadores de inflamações crônicas focais induzidas por material inerte. A dinâmica populacional de células mielóides dirigidas ao suporte inerte foi medida a partir do quarto dia após inoculação intraperitonial de 90-100 cistos de T. gondii, ao longo de vinte dias, e comparada com o percentual relativo de leucócitos sangüíneos. Observou-se uma diminuição do percentual de PMN e um aumento significativo de Mø no sangue dos animais infectados. A infecção assintomática por T. gondii em camundongos resultou em um maior esforço do sistema mielóide na produção de células destinadas a combater focos inflamatórios, tornando-as menos aptas a responder adequadamente a diferentes fontes de infecção crônica. A mudança na maturidade e nas proporções normais de células mielóides indicou haver um bloqueio da extrusão de quimiocinas responsáveis pela atração quimiotática de PMN com comprometimento da resolução de focos inflamatórios durante infecções crônicas e assintomáticas por Toxoplasma gondii.<br>Cells of the mononuclear and polymorphonuclear series were analyzed throughout the course of Toxoplasma gondii infections of C57 BL/6 female mice with chronic inflammatory foci. The animals were inoculated intraperitoneally with 90-100 parasitic cysts followed by subcutaneous implantation of cover glasses (after 4 days). The shift of leukocytes from the blood to the inflammatory focus, corresponding to a prolonged infiltration of myeloid cells, was measured in a time course of 20 days. A significant decline was observed in the mature polymorphonuclear cells in the blood and a concomitant development of a marked monocytosis. Infections with T. gondii in mice with chronic inflammatory foci resulted in dedication of the entire myeloid cells system to the generation of cells that were exported to combat the inflammation, which occurred in those places, and to the chronic infection itself. The shift in the normal proportions of cells and in cells of different degrees of maturity, suggesting that a blockade in the chemokines extruded to attract polimorphonuclear cells, might account to a large extent for the failure of immune responses commonly associated with Toxoplasma subclinical infections